Gary S. Balkema Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gary S. Balkema.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gary S. Balkema. Gary S. Balkema is a Director in BRADY CORP ($BRC) and a Director in PLx Pharma Inc. ($DPRX).
Address: 6555 WEST GOOD HOPE ROAD P.O. BOX 571 MILWAUKEE 53223 WI
Companies in which Gary S. Balkema is an Insider
BRADY CORP
Industry: MISCELLANEOUS MANUFACTURING INDUSTRIES [3990]
Position of Gary S. Balkema: Director
Holdings: 15,564 shares
Current Value: $552,522
Latest Transaction: Feb 23 2021
$BRC Market Capitalization: $1.79B
$BRC Previous Close: $35.50
Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions
Last 3 Months Overview:
Buy: 7x
Sell: 1x
Shares Bought: 18,210
Shares Sold: 2,266
Share Difference: +15,944
Value Difference: -$555,445
PLx Pharma Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gary S. Balkema: Director
Holdings: 5,445 shares
Current Value: $7,351
Latest Transaction: Nov 20 2020
$PLXP Market Capitalization: $15.01M
$PLXP Previous Close: $1.35
Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions
Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 5,445
Shares Sold: 0
Share Difference: +5,445
Value Difference: $0
Latest Insider Trading Transactions of Gary S. Balkema
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | BRC | BRADY CORP | Balkema Gary S. | Director | Option Exercise | M | 27.00 | 4,250 | 114,750 | 0 | |
| Feb 23 2021 | BRC | BRADY CORP | Balkema Gary S. | Director | Payment of Exercise | F | 50.64 | 2,266 | 114,750 | 13,298 | 15.6 K to 13.3 K (-14.56 %) |
| Feb 23 2021 | BRC | BRADY CORP | Balkema Gary S. | Director | Buy | M | 27.00 | 4,250 | 114,750 | 15,564 | 11.3 K to 15.6 K (+37.56 %) |
| Nov 20 2020 | PLXP | PLx Pharma Inc. | Balkema Gary S. | Director | Option Exercise | A | 5.15 | 40,000 | 206,000 | 40,000 | |
| Oct 01 2020 | BRC | BRADY CORP | Balkema Gary S. | Director | Grant | A | 39.92 | 2,731 | 109,022 | 22,835 | 20.1 K to 22.8 K (+13.58 %) |
| Mar 24 2020 | PLXP | PLx Pharma Inc. | Balkema Gary S. | Director | Option Exercise | A | 2.16 | 20,000 | 43,200 | 20,000 | |
| Sep 24 2019 | BRC | BRADY CORP | Balkema Gary S. | Director | Grant | A | 54.05 | 2,017 | 109,019 | 19,758 | 17.7 K to 19.8 K (+11.37 %) |